Videos

Podcasts

Articles

Gynecologic Cancer

CURE’s gynecologic cancer page is an extensive resource of cancer information featuring the latest gynecologic cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on gynecologic cancer.

Avastin appears to reduce relative risk of disease progression in recurring ovarian cancer.

Avastin Continues to Show Impressive Results in Ovarian Cancer

Ovarian cancer survivor, Annette Leal Mattern, offers up advice on living with metastatic disease.

Words of Wisdom

Researchers are looking for effective screening methods for ovarian cancer.

CA-125: What the Numbers Tell Us

Breaking Out of the Silence

The latest in cancer prevention, diagnosis & treatment 

Pipeline

PARP inhibitors continue to look “promising.”

A New Hope

For those weighing whether to get their BRCA mutation status checked, the  potential promise of the PARP inhibitors shouldn’t tip the balance&mdash;yet.

Weighing BRCA Mutation Testing

Researchers have developed a new screening approach that produces very few false positives in postmenopausal women with an average risk of ovarian cancer.

New Ovarian Cancer Screening Method Shows Promise

Continued use of the targeted drug Avastin (bevacizumab), after initial  treatment with the drug and chemotherapy, helped slow progression of advanced  ovarian cancer, according to a phase 3 study.

Longer Use of Avastin Slows Ovarian Cancer

Updates from the annual meeting of the American Society of Clinical Oncology. 

ASCO Updates

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Ovarian Cancer | Tumor